Purpose

The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adults aged 18 or older

Exclusion Criteria

  • Pregnant - Prisoner or in police custody - Uncontrolled hyperglycemia/diabetes - Current participation in another study where the total volume of blood drawn, when added to this study blood draw volume, exceeds 500cc in an 8 week period - Any medical issue or pharmacologic exposure which, in the opinion of the study investigator, that might interfere with the study objectives - Any reason which, in the opinion of the study investigator, adds additional risk to the participant

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Basic Science
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Other
13C6-Glucose
10-25gm of 13C6-Glucose
  • Drug: 13C6-Glucose
    Compounded as 5% 13C6-Glucose in sterile water given IV over 2-4 hours as a split bolus and infusion

Recruiting Locations

Vanderbilt University Medical Center
Nashville 4644585, Tennessee 4662168 37212

More Details

Status
Recruiting
Sponsor
Vanderbilt University Medical Center

Study Contact

Matthew T Stier, M.D., Ph.D.
615-875-4978
matthew.stier@vumc.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.